IN
INNOCAN PHARMA Corp
Calidad de datos: 0%
También listada como
INNPF
UNKNOWN
|
INNP
UNKNOWN
·
Manufacturing
·
Chemicals
Comparación con Pares
vs mediana del sector Manufacturing (1385 pares)
Comparado con empresas similares en Manufacturing
|
Métrica
|
Acción
|
Mediana del Sector
|
| P/E |
— |
-1.5 |
| P/B |
— |
1.6 |
| ROE % |
— |
-54.4 |
| Net Margin % |
— |
-41.5 |
| Rev Growth 5Y % |
— |
1.7 |
| D/E |
— |
0.3 |
| Growth |
| Revenue Growth (1Y) |
N/A |
Revenue Growth (3Y) |
N/A |
| Earnings Growth (1Y) |
N/A |
Earnings Growth (3Y) |
N/A |
| Revenue Growth (5Y) |
N/A |
Earnings Growth (5Y) |
N/A |
| Profitability |
| Revenue (TTM) |
N/A |
Net Income (TTM) |
N/A |
| ROE |
N/A |
ROA |
N/A |
| Gross Margin |
N/A |
Operating Margin |
N/A |
| Net Margin |
N/A |
Free Cash Flow (TTM) |
N/A |
| ROIC |
N/A |
FCF Growth (3Y) |
N/A |
| Safety |
| Debt / Equity |
N/A |
Current Ratio |
N/A |
| Interest Coverage |
N/A |
Asset Turnover |
N/A |
| Working Capital |
N/A |
Tangible Book Value |
N/A |
| Dividends |
| Dividend Yield |
N/A |
Payout Ratio |
N/A |
| Dividend Growth (3Y) |
N/A |
Dividend Growth (5Y) |
N/A |
| Consecutive Div Years |
N/A |
|
|
| Valuation |
| P/E Ratio |
N/A |
Forward P/E |
N/A |
| P/B Ratio |
N/A |
P/S Ratio |
N/A |
| PEG Ratio |
N/A |
Forward PEG |
N/A |
| EV/EBITDA |
N/A |
Fwd EV/EBITDA |
N/A |
| Forward P/S |
N/A |
Fwd Earnings Yield |
N/A |
| FCF Yield |
N/A |
|
|
| Market Cap |
N/A |
Enterprise Value |
N/A |
| Per Share |
| EPS (Diluted TTM) |
N/A |
Revenue / Share |
N/A |
| FCF / Share |
N/A |
OCF / Share |
N/A |
| EPS CAGR (1Y) |
N/A |
EPS CAGR (5Y) |
N/A |
| EPS CAGR (10Y) |
N/A |
|
|
| Efficiency |
| CapEx / Revenue |
N/A |
FCF Conversion |
N/A |
| SBC-Adj. FCF |
N/A |
Growth Momentum |
N/A |
{"event":"ticker_viewed","properties":{"ticker":"INNP","listing_kind":"stock","pathname":"/stocks/innp","exchange":"UNKNOWN","country":"US"}}